DURECT Corporation (DRRX)
NASDAQ: DRRX · IEX Real-Time Price · USD
1.590
+0.140 (9.66%)
At close: Jul 19, 2024, 4:00 PM
1.690
+0.100 (6.29%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
DURECT Revenue
DURECT had revenue of $8.32M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $1.83M. In the year 2023, DURECT had annual revenue of $8.55M.
Revenue (ttm)
$8.32M
Revenue Growth
-57.16%
P/S Ratio
5.93
Revenue / Employee
$143,466
Employees
58
Market Cap
49.35M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 8.55M | -10.74M | -55.67% |
Dec 31, 2022 | 19.28M | 5.31M | 37.96% |
Dec 31, 2021 | 13.98M | -16.13M | -53.58% |
Dec 31, 2020 | 30.11M | 5.04M | 20.09% |
Dec 31, 2019 | 25.07M | 9.80M | 64.15% |
Dec 31, 2018 | 15.28M | -33.90M | -68.93% |
Dec 31, 2017 | 49.17M | 35.15M | 250.59% |
Dec 31, 2016 | 14.03M | -5.10M | -26.66% |
Dec 31, 2015 | 19.12M | -277.00K | -1.43% |
Dec 31, 2014 | 19.40M | 4.08M | 26.59% |
Dec 31, 2013 | 15.33M | -37.74M | -71.12% |
Dec 31, 2012 | 53.07M | 19.58M | 58.48% |
Dec 31, 2011 | 33.49M | 1.90M | 6.00% |
Dec 31, 2010 | 31.59M | 7.13M | 29.15% |
Dec 31, 2009 | 24.46M | -4.08M | -14.28% |
Dec 31, 2008 | 28.54M | -2.14M | -6.98% |
Dec 31, 2007 | 30.68M | 8.78M | 40.11% |
Dec 31, 2006 | 21.89M | -6.68M | -23.37% |
Dec 31, 2005 | 28.57M | 14.72M | 106.24% |
Dec 31, 2004 | 13.85M | 2.02M | 17.05% |
Dec 31, 2003 | 11.84M | 4.65M | 64.72% |
Dec 31, 2002 | 7.19M | 661.00K | 10.13% |
Dec 31, 2001 | 6.52M | 3.37M | 106.78% |
Dec 31, 2000 | 3.16M | 3.07M | 3,568.60% |
Dec 31, 1999 | 86.00K | - | - |
Dec 31, 1998 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionDRRX News
- 2 months ago - DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis - PRNewsWire
- 2 months ago - DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update - PRNewsWire
- 2 months ago - DURECT Corporation to Announce First Quarter 2024 Financial Results and Provide a Business Update - PRNewsWire
- 2 months ago - DURECT Corporation Announces Late-Breaking Oral Presentation at the EASL Congress 2024 to Discuss AHFIRM Phase 2b Data in Alcohol-Associated Hepatitis - PRNewsWire
- 4 months ago - DURECT Corporation Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update - PRNewsWire
- 4 months ago - DURECT Corporation to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide a Business Update - PRNewsWire
- 5 months ago - DURECT and Charles River Laboratories Enter into Co-Marketing and Collaboration Agreement for ALZET® Product Line in U.S. and Canada - PRNewsWire
- 5 months ago - DURECT Corporation to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference - PRNewsWire